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Summary
Using calmodulin antagonism as a model, it is de-
monstrated that, under circumstances in which bind-
ing sites are motionally independent, it is possible to
create bifunctional ligands that bind with significant
affinity enhancement over their monofunctional coun-
terparts. Suitable head groups were identified by
using a semiquantitative screen of monofunctional
tryptophan analogs. Two bifunctional ligands, which
contained two copies of the highest-affinity head
group tethered by rigid linkers, were synthesized. The
bifunctional ligands bound to calmodulin with a stoi-
chiometry of 1:1 and with an affinity enhancement
over their monofunctional counterparts; the latter
bound with a stoichiometry of 2:1 ligand:protein. A
lower limit to the effective concentrations of the do-
mains of calmodulin relative to each other (0.2–2 mM)
was determined. A comparable effective concentra-
tion was achieved for bifunctional ligands based on
higher-affinity naphthalene sulphonamide derivatives.
Introduction
A successful strategy to design ligands to biological
macromolecules, which have both high affinity and high
specificity, is to link together two lower-affinity ligands
[1, 2]. Such an affinity enhancement, however, is by no
means assured [3, 4]. It depends on (1) how much the
binding conformation of the macromolecule is perturbed
away from the optimum given the restraints imposed
by accommodating the linked compound, (2) how large
an entropic loss in the target molecule is required by*Correspondence: j.waltho@shef.ac.ukthe binding, and (3) how much flexibility the linked com-
pound is required to lose in the linker upon binding. All
of these components combine to determine the effec-
tive concentration for the second interaction. The mag-
nitude of this effective concentration, Ceff, is reflected
in any enhanced affinity of the bifunctional ligand over the
corresponding monofunctional ligands and is given by:
Ceff =
KdAKdB
KAB
(1)
where A and B represent two moieties of a bifunctional
ligand, AB, for which the dissociation constants as
monofunctional ligands (KdA and KdB) are known. To
achieve simultaneous binding of, for example, two do-
mains to one ligand, the value of Ceff needs to be larger
than the dissociation constant of the weaker binding
monofunctional moiety. In this scenario, Ceff is also the
concentration at which the formation of linear polymers
of receptors linked by bifunctional ligands begins to
compete effectively with 1:1 binding. Thus, if the value
of Ceff can be determined (or at least a lower limit of
its value), this provides a quantitative measure of the
minimum affinity that must be achieved by the compo-
nent moieties of a bifunctional ligand, if binding in a
bifunctional mode is to provide an improvement in af-
finity. As an example, for a protein that binds to a mono-
functional ligand with a dissociation constant of 1 M,
a Ceff value greater than 1 M will ensure that the simul-
taneous participation of both domains in a complex
with the target is the preferred state (Equation 2).
Enhancement of bifunctional binding =
KdA
KdAB
=
Ceff
KdA
(2)
To date, applications of linked bifunctional ligands for
biological macromolecular receptors have focused on
macromolecules containing adjacent ligand binding
sites that are in a fixed positional relationship to one
another. Reported examples of linked ligands include a
wide variety of multisubstrate analogs, including bisub-
strate analog inhibitors for a range of enzymes. For ex-
ample, the design of linked ligands was developed em-
pirically based on models of transition state complexes
involving two substrates and has led to affinity en-
hancements of 2–5 orders of magnitude [5–10]. Multi-
substrate ligands also largely involve rigid linkers, in-
cluding examples that have been either designed [11]
or selected by combinatorial methods [12] to be closely
complementary to protein sites that, again, have fixed
positional relationships. An alternative strategy, devel-
oped for a homo-multimeric protein with binding sites
in fixed positional relationships [13], utilizes highly flexi-
ble linkers between two ligand moieties. The linkers do
not become immobilized upon binding, but determine,
according to their length, the effective concentration of
the two head groups.
The use of bifunctional ligands for multidomain pro-
teins that have ligand binding sites that are not fixed in
position relative to each other, though, has been largely
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90overlooked [14]. However, a corollary of the successful v
ause of flexible ligands for rigid binding sites [13] is that
eit should be achievable to attain increased binding af-
lfinity to proteins with motionally independent binding
asites by using ligands connected by fixed linkers, if a
isufficiently high effective concentration can be at-
ltained. Although effective concentrations as high as
l10–100 M have been reported for complexes between
mbidentate ligands and nonprotein receptors in which
bthe binding site orientations are fixed, these values are
lgreatly reduced for the equivalent compounds in com-
lplexes in which the binding sites have relative motion
r[15]. In addition, the reported effective concentrations
aattained between linked ligands and proteins rarely ap-
aproach the values attained for nonprotein receptors,
aeven when the binding sites have relatively fixed orien-
ptations and positions [1]. Therefore, if bifunctional li-
gands with enhanced affinity are to be developed for
binding sites that are not in fixed relative positions, it is R
important to establish a strategy by which the effective
concentration of a second interaction can be readily I
measured in order to ascertain whether linked ligands l
are likely to be an improvement over their monofunc- t
tional counterparts. i
Here, we show how a limit on Ceff can be readily i
lestablished for a protein, in which the ligand binding
lsites are motionally independent, by using small, rigid,
tlinked ligands. We illustrate the strategy by using the
mubiquitous calcium signal transducer calmodulin (CaM)
aas a representative example (Figure 1). CaM is comprised
bof two highly homologous domains, each of which con-
tains a hydrophobic surface, exposed upon binding of
calcium ions [16–18], and binds to a variety of hydropho- P
bic, small-molecule antagonists [19, 20]. The binding of I
numerous such monofunctional ligands has been char- l
acterized both thermodynamically and structurally [21– a
25]. Motional independence between the two domains n
when CaM is unliganded has been clearly demon- t
strated [26–28], and the protein is known to use both C
domains in the binding of recognition sequences of a
target proteins in a closed conformation [29–31], imply- s
ing that a high value of Ceff can be achieved despite the t
trelative motion of the unliganded form. However, theFigure 1. A Schematic Representation of the
Closure of CaM in Response to a Bifunc-
tional Ligand
Calcium-loaded CaM (left) displays motional
independence of the two domains, each of
which has a hydrophobic pocket capable of
binding a tryptophan moiety. In order to ac-
commodate the bifunctional ligands con-
sisting of two linked tryptophan head groups
(right), CaM is required to form a closed con-
formation. The models are based on the pdb
entries 3cln (left) and 1cll (right), with the bi-
functional ligand inserted with MACRO-
MODEL [49]. The picture was generated with
MOLSCRIPT [50] and Raster3D [51]. Below
each model is the radius of gyration for the
state determined from small-angle X-ray
scattering distribution functions (see Figure
5) recorded on both 0.5 mM CaM and a 0.5
mM 1:1 complex between CaM and ligand
BT1 (see Figure 2B).alue of Ceff has not been established for the peptide (or
ntagonist) complexes of CaM, and the attainment of an
quivalently high effective concentration with small, linked
igands is not guaranteed for the reasons outlined
bove. In terms of ligand design, the structural sim-
larity of the two antagonist binding sites in CaM al-
owed us, in this case, to utilize symmetric bifunctional
igands, and the established ability of CaM to accom-
odate target peptides of different lengths [30] ena-
led us to synthesize a limited number of bifunctional
igands with predominantly rigid linkers of different
engths between the two recognition moieties. In gene-
al, though, the strategy can be equally applied to
symmetric ligands and a far wider series of linkers that
re synthesized either individually or combinatorially
nd selected on the basis of affinity for the target
rotein.
esults
n order to establish a value for Ceff with bifunctional
igands, the dissociation constants of the monofunc-
ional components from which the bifunctional ligand
s constructed need only to exceed Ceff. In other words,
n the scenario in which Ceff is high (e.g., in the millimo-
ar range), and therefore in which the use of bifunctional
igands could be highly advantageous, the affinity for
he target of the monofunctional components used to
easure Ceff can be relatively low, i.e., the ligands that
re linked can be relatively poor models of the optimum
inding moiety or head group.
eptide-Mimic Ligands
n the case of CaM, the first generation of bifunctional
igand that was investigated was based simply on the
mino acid tryptophan, which is a component of many
atural CaM target peptides, but only part of the moiety
hat contacts the hydrophobic surface on each of the
aM domains. Tryptophan is a convenient choice from
chemical perspective in that it possesses spectro-
copic properties that are not present in CaM and it has
he potential for simple functional group modifications
hrough which to attach a linker. Tryptophan also broadly
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91conforms to the CaM antagonist paradigm [19], which
constitutes a hydrophobic, aromatic head with a basic
tail. For CaM, the number of compounds synthesized
could be limited owing to the wealth of structural infor-
mation already available, and, therefore, the measure-
ment of Ceff is simplified experimentally by removing
the need to make many compounds and separate them
according to their affinity. The three-dimensional struc-
tures of CaM-target peptide complexes show that tryp-
tophan side chains bind within a well-defined pocket in
the hydrophobic surface of each CaM domain; the two
pockets are separated by more than 20 Å. Thus, it was
likely that bifunctional ligands based on two tryptophan
moieties should be accommodated by CaM without the
introduction of substantial strain into the protein.
Using 1D 1H NMR and ligand fluorescence, an initial
semiquantitative screen of a family of homologous, mono-
functional, tryptophan-based ligands, MT1–MT6 (Figure
2A), was carried out to select which variant of the trypto-
phan moiety was the most suitable head group for the
construction of bifunctional ligands (Figure 2B). The most
reliable estimate of the relative binding affinities of the
ligands was obtained by using pulsed gradient spin echo
(PGSE) NMR experiments [32]. These were performed on
samples with ligand:protein concentration ratios of 2:1,
and the spectra were edited according to the translational
diffusion properties of the protein. The resulting reso-
nances reflect the population of ligand that is not bound
to the protein. In Figure 3A, three examples of such dif-
fusion-edited spectra are shown, in comparison with the
spectra of the free ligands. The chemical shift changes
that occurred upon addition of protein to ligand solutions
were in the NMR fast-exchange regime. Resonances from
both CaM domains were affected simultaneously by li-
gand binding and followed identical binding isotherms,
indicating similar binding affinities for the two domains,
as observed previously for a range of monofunctionalFigure 2. The Structures of the Ligands
(A) Monofunctional tryptophan (R2 = COOR)
and tryptamine (R2 = H) ligands.
(B) The peptide-mimic bifunctional ligands,
comprising two linked MT2 moieties.
(C) The second-generation bifunctional li-
gands, based on naphthalene sulphonamide
head groups.ligands [23]. In Figure 3B, the amplitudes of the chemi-
cal shift changes observed upon binding for represen-
tative nuclei in both the protein and the ligand are sum-
marized. These data illustrate the general trend that
larger changes in chemical shift are associated with
higher-affinity binding, as determined by the PGSE
data. For ligands MT1 and MT6, the very small pertur-
bation of chemical shifts and the high residual signal
intensity in diffusion-edited spectra indicates the ab-
sence of significant interaction with CaM at millimolar
concentrations. For MT2–MT5, all probes indicate sig-
nificant interaction with CaM, with MT2 and MT3 show-
ing the strongest effects. The MT2/MT3-type head
group was therefore selected for the synthesis of bi-
functional ligands.
Based on the structures of CaM in complex with pep-
tide models of protein targets [29–31], the approximate
lengths of linkers that would accommodate the domain
separation of a closed form of CaM were estimated
(Figure 1). Two bifunctional ligands (Figure 2B) were
synthesized, each containing two identical tryptophan
head groups tethered by predominantly rigid linker
groups. A quantitative analysis of the binding affinity
was initially carried out by using NMR for the ligands
BT1, MT2, MT3, and MT7, the last being a “mono +
linker” ligand designed to probe the effects attributable
solely to the linker group (Figure 2). Again, the binding
of all ligands to CaM was in the NMR fast-exchange
regime. Examples of changes in chemical shift as the
ligand:CaM ratio is increased are shown for a mono-
and a bifunctional ligand in Figure 4A, and the derived
dissociation constants and stoichiometries for each are
summarized in Table 1.
Importantly, ligand BT1 has a 1:1 stoichiometry with
CaM, compared to the 2:1 stoichiometry of the mono-
functional ligands, including MT7. For BT1, protein
chemical shift changes were complete by 1.0 ligand
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92Figure 3. NMR Screen of Ligand Binding
(A) Aromatic region of diffusion-edited 1H NMR spectra for 1 mM
CaM samples containing two ligand equivalents (a, c, e), in com-
parison with free ligand spectra (b, d, f) for ligands (a and b) MT1,
(c and d) MT4, and (e and f) MT2. Free ligand spectra were acquired
by using 5 mM samples in D2O (MT1, MT2) or 20% d3-MeOH (MT4).
(B) Summary of NMR probes indicative of interaction between CaM
and ligands MT1–MT6. For each measurement, larger bars indicate
higher-affinity binding. Protein chemical shifts (black bars) and li-
gand indole NH chemical shifts (light-gray bars) were measured
from initial-final chemical shifts in the titration of five aliquots of 0.5
equivalents of ligand into 1 mM CaM. Diffusion-edited spectra were
derived from experiments acquired at 0% and 100% (50W) gradient
strength. The intensity of the diffusion-edited spectrum is given rel-
ative to the intensity of the PGSE spectrum with 0% gradient power
(dark-gray bars, right vertical scale). The average chemical shift
changes for aromatic ligand resonances (white bars) were mea-
sured from the difference between the diffusion-edited spectrum
F
s
band the free ligand spectrum for identifiable signals. 1Average li-
gand chemical shifts are the lower limits for MT2, due to very low- (
intensity signals. 2For MT5, the protein chemical shift change is an r
estimated maximum value, since protein I27 NH and ligand indole (
NH resonances converge upon increasing ligand:CaM ratios. (
C
sigure 4. Plots Showing the Change in Observed Signal for Repre-
entative Titrations, Together with the Lines of Best Fit Obtained
y Least-Squares Fitting of the Data
A) Normalized NMR chemical shift changes for CaM I27 amide
esonance upon addition of ligands MT2 (open circles) or BT1
filled diamonds).
B) Normalized fluorescence changes observed upon addition of
aM to peptide-mimic ligands MT2 (open circles) or BT2 (filled
quares), monitored at 350 nm and 460 nm, respectively. For con-
sistency in reported fluorescence changes, the observed values for
the BT2 experiment (decreasing fluorescence) are inverted relative
to those for MT2 (increasing fluorescence).
(C) Normalized fluorescence changes observed upon addition of
CaM to ligands BN1 (open triangles) and BN2 (filled triangles) moni-
tored at 550 nm.equivalent, indicating that the dissociation constant is
at least two orders of magnitude less than the protein
concentration (i.e., the strong binding limit). None of the
monofunctional ligands were at this limit. Although an
accurate dissociation constant for BT1 cannot there-
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93Table 1. Dissociation Constants and Stoichiometries for Interactions between CaM and Representative Monofunctional and Bifunctional
Ligands
Ligand Kd (M) Stoichiometry (Ligand:CaM) Method of Kd Determination
MT2 400 ± 100 2 NMR, fluorescence, ITC
MT3 150 ± 60 2 NMR
MT7 60 ± 25 2 NMR
BT1 w10 1 NMR, ITC
BT2 9 ± 6 1 Fluorescence
BN1 0.07 ± 0.05 1 Fluorescence
BN2 0.01 ± 0.008 1 Fluorescencefore be determined directly from this titration, the weak-
est affinity possible corresponds to a dissociation con-
stant of w10 M, whereas the fast exchange of NMR
resonances from the free and bound species indicates
that the strongest affinity possible is no greater than 1
M. NMR-monitored titrations at CaM concentrations
below the strong binding limit were supportive of a
dissociation constant in the range of 1–10 M, but a
more precise value could not be obtained owing to
limitations in sensitivity. Stoichiometric addition of bi-
functional ligands to CaM induces its transformation to
a closed form (Figure 1), as determined by small-angle
X-ray scattering. For example, the radius of gyration of
CaM falls from 21.7 to 18.7 Å upon binding of BT1 (Fig-
ure 5). This change compares closely with the fall in the
radius of gyration when comparing previously reported
values for unliganded CaM and for 1:1 MLCK-I + CaM
[33, 34].
Although the incorporation of tryptophan moieties
was intended to allow the use of ligand fluorescence
for the determination of higher-affinity dissociation con-Figure 5. SAXS Measurements of Unliganded and Bifunctional Li-
gand Bound CaM
A comparison of the distance distribution P(r) functions for
calcium-loaded CaM (solid line) and a 1:1 complex of BT1 and
calcium-loaded CaM (broken line), illustrating the compaction that
occurs upon binding of the bifunctional ligands. The radius of gyra-
tion falls from 21.7 Å to 18.7 Å upon formation of a 1:1 complex.stants, the indole fluorescence is completely quenched
by the linker group in BT1 and is largely quenched in
BT2. Only a low-intensity fluorescence signal with max-
ima at 380 and 460 nm could be observed for the latter.
From a titration of CaM into BT2 monitored by fluores-
cence (Figure 4B), the measured dissociation constant
for the 1:1 interaction is approximately 9 M (Table 1).
For the bifunctional ligand BT1, ligands MT3 and MT7
can be used to represent its two component moieties
in the determination of Ceff. BT1 binds with an affinity
enhancement of between 1 and 2 orders of magnitude
over MT3, and a factor of 5 over MT7 (Table 1). Impor-
tantly, the stoichiometry difference between the bifunc-
tional and the mono + linker ligand, MT7, indicates that
it is the second head group moiety, rather than the
presence of the linker group, that causes the bifunc-
tional binding. Using the derived dissociation constants
(Table 1), Ceff for the domains of CaM for BT1 is in the
range of w0.2–2 mM. The length of the linker groups in
BT1 and BT2 was found to make little difference to the
binding affinity, as predicted from the ability of CaM to
accommodate peptides with different relative positions
of the side chains that bind to its hydrophobic surfaces.
In principle, the major contribution of Ceff to the bind-
ing affinity is usually ascribed to an entropy term that
favors binding for bifunctional ligand-CaM complexes.
To test whether the increase in binding affinity for the
bifunctional ligands is largely the result of such an en-
tropy term, isothermal titration calorimetry (ITC) was
used to measure the changes in enthalpy (H), and
hence entropy (S), upon binding for ligands MT2 and
BT1. The dissociation constants measured by ITC (Ta-
ble 2) match within error those measured by other
methods (Table 1). Over the temperature range of 8°C–
37°C, H and S were negative for binding of both
ligands, and the negative values of Cp imply a signifi-
cant hydrophobic contribution to the binding free en-
ergy. The value of H for the bifunctional ligand is twice
that for the monofunctional ligand (within error), which
suggests that there is no substantial change in the indi-
vidual binding interactions at the two sites. However,
S for binding the bifunctional ligand is also twice
(within error) that for the monofunctional ligand; thus,
it is not possible to identify an unambiguous entropic
contribution to Ceff.
Dissecting these factors is a major challenge, so it
is impossible to reliably assign the cooperativity to an
entropy or enthalpy effect in this system.
The problem is that there are several different factors
Chemistry & Biology
94tTable 2. Thermodynamic Parameters for Monofunctional and
dBifunctional Ligand Binding to CaM Measured by ITC at 25°C
o
MT2 1:1 BT1 1:1 b
Monofunctional Bifunctional
fComplex Complex
n
Kd (M) 600 ± 100 8 ± 1 f
G (kJ mol−1) −18.3 ± 0.5 −28.6 ± 0.5
C
H (kJ mol−1) −35 ± 3 −64 ± 1
eTS (kJ mol−1 K−1) −16 ± 3 −36 ± 1
tCp (J mol−1 K−1) −1700 ± 900 −2600 ± 700
tCthat can contribute to the observed enthalpy and en-
itropy changes. For the monofunctional ligand these are:
c
o1. Binding interactions. These could make a favor-
lable contribution to H.
a2. Hydrophobic effects. These could make a favor-
dable contribution to S and an unfavorable contri-
Ibution associated with the desolvation of polar
fgroups.
g3. Restricting intermolecular motion. This will make
lan unfavorable contribution to S [35].
t4. Conformational changes in the protein and/or the
wligand. These can make favorable or unfavorable
contributions to H and S. Structural tightening
Dcould make H and S more negative, or struc-
tural loosening would make H and S more posi-
Ftive. These compensatory changes in H and S
tare often very large relative to the size of the effect
cdiscussed here [36].
i
bFor the bifunctional ligand, the magnitude of these
geffects will differ from the monofunctional system. The
ccontributions from (1) and (2) should be approximately
qdouble those for the monofunctional ligand, and the con-
p
tribution from (3) should be similar. However, in the bifunc-
r
tional case, there is additional restriction of the conforma-
g
tions of the linkers between the two protein domains and w
the tryptophan moieties that will compensate the entropic h
advantage of the bifunctional ligand to some extent. c
C
Naphthalene Ligands t
Despite the relatively low affinity of tryptophan-based t
monofunctional ligands, the range measured for Ceff is s
sufficient to lead to a modest affinity enhancement for s
the equivalent bifunctional ligands. However, if this t
range of Ceff can be maintained, it follows from Equa- c
tion 1 that a larger enhancement of affinity should be u
achievable for bifunctional ligands starting from mono- t
functional moieties with higher affinities than MT1–MT7.
To demonstrate this, a second generation of bifunc- m
tional ligands, BN1 and BN2 (Figure 2C), was synthe- s
sized. In this generation of ligands, the linkers were a
based on the peptide-mimic bifunctional ligands, but two t
naphthalene sulphonamide head groups were used in C
place of the tryptophan moieties. Naphthalene sulphon- v
amides bind to the same sites of CaM as tryptophan d
derivatives, as indicated by the distribution of chemical a
shift changes in the protein upon addition of ligand [23, d
24], and are a feature of numerous monofunctional CaM t
antagonists that bind with dissociation constants in the s
irange of 1–10 M [19, 23, 24], i.e., 1–2 orders of magni-ude more strongly than the monofunctional tryptophan
erivatives. The linker groups were chosen to give
verall ligand lengths comparable to the tryptophan-
ased bifunctional ligands. The dissociation constants
or BN1 and BN2 were determined to be 70 nM and 10
M, respectively (Table 1), by using changes in intrinsic
luorescence of the ligand at 550 nm upon titration of
aM into a solution of the ligand. The stoichiometry for
ach binding event was confirmed as 1:1 by using a
itration of ligand to CaM at concentrations of ten times
he determined dissociation constants.
Thus, the simple bifunctional derivative BN2 binds to
aM with a 1:1 stoichiometry and an affinity approach-
ng that of peptides corresponding to the natural re-
ognition target of CaM. This affinity is some 2–3 orders
f magnitude stronger than that of any monofunctional
igand equivalent and indicates that this second gener-
tion of ligand was no more limited in Ceff by the linker
esign than the tryptophan-based bifunctional ligands.
n other words, on the basis of the range determined
or Ceff by using the tryptophan-based bifunctional li-
ands, it was straightforward to design a bifunctional
igand that greatly exceeded its monofunctional coun-
erparts in affinity and that binds CaM in competition
ith its physiological partners.
iscussion
rom the example of ligand binding to CaM, it is clear
hat ligands that are bound to biological macromole-
ules with enhanced affinity can be derived by the link-
ng together of two lower-affinity ligands even when the
inding sites are mobile relative to each other. The de-
ree of affinity enhancement is related to the effective
oncentration, Ceff, of the second binding event, a
uantity that can be readily determined by using sim-
le, low-affinity head groups connected by relatively
igid linkers. The monofunctional tryptophan-based li-
ands that were linked in the present study and that
ere sufficient to determine the value of Ceff for CaM
ave a low affinity for CaM (Table 1), and this affinity is
onsiderably lower than traditional monofunctional
aM antagonists, such as J-8 and trifluoperazine. Rela-
ive to the latter, binding is likely to be disfavored by
he indole NH group of the tryptophan moiety that con-
titutes a hydrogen bonding potential that is not pre-
ent in the other ligands, and that is not satisfied by
he ligand binding site. The absence of a significant
hange in the chemical shift of the indole NH resonance
pon binding (see Figure 3B) supports this, indicating
hat its solvation state is retained in the complex.
Paradoxically, ligand MT6 is melatonin, a neurotrans-
itter reported to inhibit CaM-dependent activation of
ome enzymes [37] and to have a picomolar dissoci-
tion constant for CaM [38], i.e., even stronger binding
han the nano-molar affinities of target enzymes for
aM [39]. However, in agreement with data from a pre-
ious study [40], the results obtained here reveal a
issociation constant weaker than 1 mM for melatonin
nd indicate that substitution of the indole ring further
isfavors binding to CaM. Furthermore, the weak in-
eraction of ligand MT1 with CaM compared to the
tronger binding of ligands MT2 and MT3 suggests that
t is not the presence of a positive charge that favors
Receptors with Mobile Binding Sites
95CaM binding, as proposed in the paradigm molecule
[19], but that a negative charge is detrimental to
binding.
The range of Ceff values determined here (0.2–2 mM)
represent a lower limit for that achievable for the do-
mains of CaM. Despite each linker in the bifunctional
ligands being predominantly rigid, six rotatable bonds
separate the two indole moieties in the tryptophan-
derived bifunctional ligands, and four rotatable bonds
separare the moieties in the naphthalene sulphonamide
bifunctional ligands. Although this flexibility may help
alleviate constraints imposed by suboptimal orientation
and separation of the head groups, any restriction of
rotors would ameliorate the benefits, leading to a com-
promise in affinity enhancement and a corresponding
lowering of Ceff. Naturally, ligands requiring the restric-
tion of too many rotors or with inappropriately oriented
or separated head groups will have effective concentra-
tions below the dissociation constant of the corre-
sponding monofunctional ligands; thus, 2:1 stoichiome-
try binding will dominate the equilibrium, and any
affinity enhancement is lost. Conversely, more rigid li-
gands with appropriate head group orientation and
separation have the potential for considerably en-
hanced affinity over that reported here.
As would be expected for many multidomain pro-
teins, a relatively high effective concentration of the two
domains of CaM is reflected in its mode of action. The
coupling of the two domains by the tether limits the free
energy loss resulting from the conformational selection
required to bring the two domains together upon for-
mation of complexes with the target proteins. The co-
operative behavior of the two domains at cellular
calcium levels is also further moderated by the differ-
ences in their calcium affinities [41]. Moreover, CaM ac-
commodates multiple target proteins that present a
variety of binding regions. Interdomain flexibility is a
convenient means of relaxing the constraints on sub-
strate specificity, while tethering maintains a large
enough effective concentration to illicit cooperative
binding. The CaM system also restricts its free energy
loss upon cooperative binding of the two domains by
the behavior of the tether in the CaM-peptide com-
plexes. Upon binding peptides, not all of the region be-
tween the two domains is conformationally frozen, evi-
denced by the absence of electron density in this
region in the crystal structure of the CaM-CaMKII pep-
tide complex [30]. Overrestriction of the tether would
diminish the affinity of the two-domain complex in an
analogous manner to the overrestriction of rotamers in
the bifunctional ligands described above.
Significance
The results presented here for CaM clearly illustrate
the value in utilizing linked ligands for enhancing the
binding affinity of ligands to proteins with motionally
independent binding sites, and the value of quantify-
ing a lower limit on the achievable effective concen-
tration for multidentate interactions by using simple
head groups with, in this case, millimolar dissociation
constants. While the mechanism of action of CaM
strongly hints at the potential advantage of using bi-functional ligands, which turned out to be highly suc-
cessful, many systems for which an equivalent strat-
egy could be equally successful will not be so well
defined in terms of structure and affinity measure-
ments. Nevertheless, knowledge about any indepen-
dent ligand binding properties, regardless of any ap-
parent relative motion of the parts of the protein
involved in that binding, should be sufficient to de-
sign simple, linked ligands with which to test the
achievable values of Ceff in an analogous manner to
that described above for CaM. In other words, the ob-
servation of relative motion between potential ligand
binding sites should not deter the investigation of
linked ligands as high-affinity derivatives. The nature
of the tether between the ligand binding sites can
maintain considerable relative proximity.
Experimental Procedures
Materials
All ligands (Figure 2) are named with a prefix “XY,” according to
their class, where X = M or B depending on whether the ligand is
monofunctional or bifunctional, respectively, and Y = T or N depend-
ing on whether the head group is based on tryptophan or naphtha-
lene, respectively. Ligands MT1 (L-tryptophan), MT2 (L-tryptophan
methyl-ester, hydrochloride salt), MT4 (tryptamine), and MT6
(5-methoxy-N-acetyl tryptamine) were obtained commercially and
were used without further purification.
Ligand Synthesis
Modifications to ligands MT2 and MT4 were performed by using
the following protocol, where the term “acid chloride” refers to the
acetyl chloride for acetylation (MT2 / MT3, MT4 / MT5) or the
benzoyl chloride for benzoylation (MT2 / MT7) reactions. A total
of 1 mmol of the free amine (MT2 or MT4) was dissolved in dry
dichloromethane (DCM) with two equivalents of triethylamine
(Et3N); one equivalent of the acid chloride was then added drop-
wise at 0°C. The reaction mixture was stirred at room temperature
for 1 hr. The organic phase was washed in 1 M HCl, washed to
neutral with H2O, and dried over anhydrous sodium sulfate
(Na2SO4). Where necessary, further purification was achieved by
silica gel chromatography in 9:1 ethyl-acetate:petroleum-ether so-
lution. The products were recrystallized by slow diffusion of petro-
leum ether into DCM.
The synthesis for bifunctional ligands BT1 and BT2 involved the
coupling of two MT2 moieties by a di-acid chloride linker molecule
using a method analogous to the N modifications described above.
The acid chlorides corresponding to the di-acid linkers (Figure 2B)
were formed by activation of the di-acid with oxalyl chloride, by
using DCM as solvent and dimethylformamide (DMF) as a catalyst.
A total of 2 mmol MT2 was dissolved in dry DCM with two equiva-
lents of Et3N. 0.5 equivalents of the acid chloride was added step-
wise at 0°C. The reaction was left stirring at room temperature for
12 hr, and the products were isolated as described above.
The method used for the synthesis of the bifunctional naphtha-
lene sulphonamide ligands is a modification of a previously pub-
lished protocol [42]. Ligands BN1 and BN2 (Figure 2C) were synthe-
sized by linking two 1-naphthalene sulphonylchloride moieties with
p-xylylenediamine or m-xylylenediamine, respectively. A total of
1 mmol xylylenediamine was dissolved in 7.5 ml dry DCM, and
three equivalents of Et3N were added under nitrogen (N2). A total
of 2 mmol 1-naphthalene sulphonylchloride was dissolved in an
equivalent volume of dry DCM and added dropwise to the
xylylenediamine/Et3N mixture at room temperature under N2. The
reaction was left stirring at room temperature overnight under N2.
The reaction mixture was then washed in 1 M sodium hydroxide
(aqueous), and the organic layer was removed. The aqueous layer
was further washed twice with dry DCM. All organic washes were
pooled and dried over anhydrous Na2SO4. The products were
recrystallized by slow diffusion of hexane into DCM.
The characterization of each new compound by NMR and ele-
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96mental analysis is provided in the Supplemental Data (available s
with this article online). Stock solutions of the ligand samples were o
prepared by dissolution of recrystallized material in water, MeOH, 
or DMSO as appropriate. a
t
CaM Preparation t
Protein samples were prepared from lyophilized recombinant mam- t
malian CaM [43–45] by dissolution in 50 mM KCl, 10 mM CaCl2, p
0.5 mM NaN3 (pH 6.0). Protein concentrations were quantified by e
titration with Ca2+ monitored by 1H NMR. All experiments were car- e
ried out at 298K. t
t
NMR Spectroscopy f
Spectra were acquired with Bruker AMX-500 or DRX-500 spec- t
trometers. Spectral widths were 12,500 Hz, and relaxation delays e
were typically 0.7 s for protein spectra and 3 s for ligand spectra.
Solvent suppression was achieved by using presaturation. PGSE Sexperiments [32] included a composite 180° pulse to refocus the
Dmagnetization in the center of a delay between two identical gradi-
vents. Sine-shaped gradient pulses of 8 ms duration were used, with
ca center-to-center separation of 10.7 ms. Experiments were ac-
nquired at 0% and 100% gradient strength in order to obtain
diffusion-edited spectra [46]. All experiments were acquired with a
2.5 ms preacquisition Hahn echo [47], and the water resonance
Swas removed with a convolution difference filter by using FELIX
S(Accelrys, San Diego).
p
cFluorescence Spectroscopy
Experiments were performed with HITACHI-4500 and Shimadzu
RF-5301 fluorescence spectrophotometers. For the peptide mimic
ligands MT2 and BT2, fluorescence emissions between 300 and A
400 nm upon excitation at 295 nm (MT2) or between 335 and 550
nm upon excitation at 320 nm (BT2) were monitored for titrations W
of 0.5 mM CaM in KCl/CaCl2 into 5 M ligand in 10% MeOH. The o
conformation of CaM is not significantly affected by the addition of T
10% MeOH or 10% DMSO (see below), as determined by measur- c
ing 1H,15H HSQC NMR spectra as a function of solvent composition s
(data not shown). For ligands BN1 and BN2, titrations of 0.01 mM r
CaM into 1 M ligand in 0.1% or 10% DMSO were monitored be-
I
tween 525–575 nm with excitation at 275 nm. Slit widths were 2.5
nm and 5 nm for excitation and emission, respectively. For each
ligand, control dilutions of ligand with KCl/CaCl2 solution and of R
CaM into KCl/CaCl2 solution were performed under the same con- R
ditions. The change in fluorescence intensity at 350 nm (MT2), 460 A
nm (BT2), or 550 nm (BN1, BN2) was used in data fitting to deter- P
mine the dissociation constants for the interactions.
R
Determination of Dissociation Contants
Dissociation constants were derived by monitoring chemical shift
changes of CaM resonances upon addition of increasing ligand
concentrations or ligand fluorescence intensity changes upon ad-
dition of increasing CaM concentrations. Data fitting was per-
formed by using n:1 stoichiometry, where n sites are equivalent and
independent. Interaction stoichiometries were determined by the
model best fitting the data (minimum χ2 value), both when fitting
with integral values for n and when including n as a variable. The
fit of the fluorescence data included a slope to accommodate a
linear dependence of the fluorescence upon increasing CaM con-
centration, observed in the control dilutions outlined above.
Isothermal Titration Calorimetry
The enthalpy associated with CaM binding was determined by iso-
thermal titration calorimetry for MT2 and BT1. Experiments were
performed on a VP-ITC titration calorimeter (Microcal Inc., North-
hampton MA). Experiments were performed at least twice. Since
BT1 is not soluble at high concentration, dilution of the CaM com-
plex was used to measure the enthalpy of dissociation of the com-
plex. Lyophilized apoCaM was dissolved in unbuffered 100 mM
KCl, 4 mM CaCl2, 0.5 mM NaN3 and dialyzed overnight against the
same solution. MT2 or BT1 was dissolved in methanol and added
to the stock protein solution (0.4–0.5 mM) to a final concentration
of 210 M for BT1 and 1.4 mM for MT2, and the final methanol
content was adjusted to be 5% (v/v). All solutions were degassed
for 1 min to minimize evaporation of the methanol. The (MT2)2:CaM
or BT1:CaM complex was placed in the syringe. The solution
placed in the cell was that used above for the dialysis of CaM,upplemented with 5% methanol, i.e., it is identical to the contents
f the syringe, except for the ligand:CaM complex. Aliquots (10–15
l for MT2 and 15–20 µl for BT1) of the ligand:Cam complexes were
dded to the cell, and the data were fit to a dissociation isotherm
o obtain the stoichiometry (n), the enthalpy of binding (H), and
he dissociation constant (Kd). The enthalpy associated with dilu-
ion of CaM or ligand solutions was also measured by injecting
ure ligand and pure CaM solutions separately into the cell, but the
ffects were small compared with dilution of the complexes. The
xperiments were repeated at 8°C, 16°C, 25, and 32°C, and the
emperature dependence of the enthalpy changes was used to ob-
ain the values of Cp. The high dissociation constant of the mono-
unctional ligand MT1 resulted in relatively small heat effects, and
he data for this ligand are therefore subject to a significantly larger
rror than are data for the strong binding ligand BT1.
AXS Measurements
istance distribution functions were derived as described pre-
iously [48]. Protein concentrations exceeded the minimum disso-
iation constants of the chosen ligand by at least one order of mag-
itude.
upplemental Data
upplemental Data including the characterization of the com-
ounds prepared during this study are available at http://www.
hembiol.com/cgi/content/full/12/1/89/DC1/.
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